Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHives on semaglutide do occur, though they are uncommon. The skin reaction typically appears as raised, itchy welts and may signal a local injection response or, in rare cases, a broader allergic reaction requiring prompt medical attention. Most people taking Wegovy never experience them, but knowing what to look for matters. Semaglutide is a prescription-only medicine; a clinical assessment decides whether it is right for you, and any new or worsening skin reaction while you are on it should go back to your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide is a GLP-1 receptor agonist — it mimics a gut hormone to reduce appetite and slow the rate at which food leaves the stomach. That mechanism has nothing to do with skin directly, yet some people do develop skin reactions, most commonly at or near the injection site. The reasons are not fully understood, but two broad explanations are offered in the clinical literature: a local response to the injection itself (the needle, the formulation, or the technique), and a systemic immune reaction to the medicine as a foreign protein.
Hives specifically (the raised, blotchy, intensely itchy welts known medically as urticaria) are listed in the NHS patient information for semaglutide as an uncommon side effect, meaning they affect fewer than one in a hundred users but more than one in a thousand. That is a small but real proportion of people. The NHS page advises telling your doctor or pharmacist if hives appear, so the reaction is taken seriously in prescribing guidance even when it is not classified as common.
Injection technique is worth considering first. Rotating sites (abdomen, thigh, upper arm) and cleaning the skin beforehand can reduce irritation. If the reaction is confined to the spot you injected and fades within an hour or two, a local cause is the more likely explanation. If the welts spread, or if the same small reaction appears every week regardless of where you inject, the picture is different and your prescriber needs to know.
The most important question with any allergic skin response is whether it is staying local or going systemic. Hives that stay on the surface, itch for a few hours, and then clear are uncomfortable but rarely dangerous. Hives that spread rapidly, are accompanied by facial or throat swelling, wheezing, tightness in the chest, or a sudden drop in blood pressure are the hallmarks of anaphylaxis, a severe, life-threatening allergic reaction.
If you or someone with you develops those symptoms after a semaglutide injection, call 999 immediately. Do not wait to see if it settles. The MHRA's Yellow Card reporting service also allows patients and healthcare professionals to report suspected side effects of medicines, and a serious allergic reaction is exactly the kind of event the scheme exists to capture.
Between the two extremes sit moderate reactions: hives that are widespread but stable, with no breathing or circulatory symptoms. These warrant same-day contact with your GP or prescriber rather than an emergency call, but they should not be left until your next scheduled review. A prescriber may pause the medicine while the reaction is assessed.
Worth mentioning: a question our prescribers hear fairly regularly is whether antihistamines are safe to take alongside semaglutide. Antihistamines are not contraindicated, but the decision to use them and at what dose sits with your prescriber, not a search result.
That depends entirely on the nature of the reaction, and the decision is your prescriber's to make, not something to self-manage based on general guidance. Some people develop a mild local reaction that settles as they become accustomed to the medicine and never recurs at a higher dose. Others find that hives return predictably with each injection, signalling that the medicine is not well tolerated.
If a clear link between semaglutide and hives is established and the reaction is more than trivial, the prescriber may consider whether continuing at the current dose, pausing, switching to a different formulation, or stopping treatment altogether is the appropriate course. The alternative for weight management in the UK is Wegovy, which is the branded form of semaglutide, or tirzepatide (Mounjaro), which works through a different receptor pathway and may be better tolerated by some individuals. That kind of clinical comparison is one of the things covered in an initial consultation.
People transferring to a new service (or who are mid-treatment and unsure whether to continue) can find a short overview of how the assessment process works on the weight-loss treatment overview page. The process at nume always involves a prescriber reading your individual history; that context matters when you are dealing with a side effect as variable as this one.
Hives have a fairly distinctive appearance, pale or red raised welts with defined edges that move around the body and typically itch rather than hurt. They are not the same as the small red marks that can form at an injection site after a needle passes through skin, and they are not the same as bruising, lipodystrophy (fat changes under the skin from repeated injections in the same spot), or eczema flares that can sometimes be triggered by stress or hormonal shifts accompanying significant weight change.
Some people also confuse a mild rash from clothing rubbing against an injection site with a drug reaction. The key distinction is reproducibility: does the rash appear after every injection, in different locations, and does it have the classic hive pattern of transient welts? If yes, report it to your prescriber. If you are genuinely unsure what you are looking at, a same-day photo sent to your clinical team is a practical first step. Our support team is available seven days a week for exactly this kind of query between scheduled reviews.
For a more complete picture of Wegovy's side-effect profile (including the gastrointestinal effects that are more commonly discussed) the dedicated page on hives from Wegovy goes into further detail. And if you have questions about whether semaglutide is the right choice for you in the first place, the semaglutide overview covers the full licensed indications and eligibility criteria, with separate pages covering semaglutide at the starting dose and semaglutide at the maintenance dose for those who want a closer look at how the treatment progresses.
If you are currently on semaglutide and concerned about a skin reaction, speak to our prescribers for a clinical view on your specific situation. It is also worth knowing that some patients ask about combining their treatment with dietary supplements, and we have looked at what the evidence says about taking Wegovy alongside green tea for those who are curious.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.